Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.3B | 5.2B | 5.4B | 5.0B |
| Cost of revenue | 3.0B | 2.9B | 3.0B | 2.7B |
| Gross profit | 2.3B | 2.2B | 2.5B | 2.3B |
| Operating expense | ||||
| Research & development | 302M | 343M | 302M | 299M |
| Selling general and admin | 1.3B | 1.3B | 1.3B | 1.2B |
| Other operating expenses | 45M | 28M | 136M | 98M |
| Operating income | 637M | 546M | 793M | 714M |
| Non operating interest income | ||||
| Income | 5M | 23M | 55M | 48M |
| Expense | 151M | 155M | 155M | 137M |
| Other income expense | -128M | -108M | -179M | -125M |
| Pretax income | 363M | 306M | 514M | 500M |
| Tax provision | 55M | 3M | 114M | 13M |
| Net income | 308M | 303M | 400M | 487M |
| Basic EPS | 1.1 | 1.1 | 1.5 | 1.7 |
| Diluted EPS | 1.1 | 1.0 | 1.5 | 1.7 |
| Basic average shares | 287.3M | 289.5M | 289.6M | 289.6M |
| Diluted average shares | 287.7M | 290.4M | 290.6M | 290.3M |
| EBITDA | 1.2B | 1.2B | 1.5B | 1.3B |
| Net income from continuing op. | 308M | 303M | 400M | 487M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |